Mainz Biomed BV banner

Mainz Biomed BV
NASDAQ:MYNZ

Watchlist Manager
Mainz Biomed BV Logo
Mainz Biomed BV
NASDAQ:MYNZ
Watchlist
Price: 0.6 USD 5.26% Market Closed
Market Cap: $5.4m

Wall Street
Price Targets

MYNZ Price Targets Summary
Mainz Biomed BV

There are no price targets for MYNZ.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Mainz Biomed BV Competitors:
Price Targets
STG
Strip Tinning Holdings PLC
149% Upside
WLFC
Willis Lease Finance Corp
10% Upside
FLB
Fluidigm Corp
71% Upside
RYI
Ryerson Holding Corp
43% Upside

Revenue
Forecast

16% / Year
Past Growth
142% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss
16% / Year
Past Growth
142% / Year
Estimated Growth
Estimates Accuracy
-17%
Average Miss

For the last 4 years the compound annual growth rate for Mainz Biomed BV's revenue is 16%. The projected CAGR for the next 4 years is 142%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MYNZ's stock price target?
Not Available

MYNZ doesn't have any price targets made by Wall Street professionals.

What is Mainz Biomed BV's Revenue forecast?
Projected CAGR
142%

For the last 4 years the compound annual growth rate for Mainz Biomed BV's revenue is 16%. The projected CAGR for the next 4 years is 142%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett